[VYNE] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
28-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -36.95%
YoY- -89.65%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 6 2,292 4,286 0 -10,640 2,775 450 -51.28%
PBT -7,748 -12,018 -23,181 -21,498 -17,594 -9,277 -4,837 8.16%
Tax 13 -448 -258 -52,379 -11 -2 0 -
NP -7,761 -11,570 -23,181 -21,498 -17,594 -9,277 -4,837 8.19%
Tax Rate - - - - - - - -
Total Cost 7,767 13,862 27,467 21,498 6,954 12,052 5,287 6.61%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -129,350.00 -504.80 -540.85 0.00 165.36 -334.31 -1,074.89 122.11%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -2.60 -3.89 -8.54 -64.36 -54.68 -32.43 -30.18 -33.53%
EPS Diluted -2.60 -3.89 -8.54 -64.36 -54.68 -32.43 -30.18 -33.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.